Daniel Appelbaum to Receptors, Peptide
This is a "connection" page, showing publications Daniel Appelbaum has written about Receptors, Peptide.
Connection Strength
0.242
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
Score: 0.242